Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
600 participants
OBSERVATIONAL
2020-03-01
2021-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Embolism in COVID-19 Positive Patients
NCT04910360
Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory Symptoms
NCT04420312
Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy
NCT04377490
Thromboembolic Events in Severe COVID-19 Patients
NCT04405869
Does COVID-19 Infection Increase the Risk of Pulmonary Embolism?
NCT04696913
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Covid-19 Patients with Pulmonary embolism
Clinically demonstared cases infected with COVID-19 who developed pulmonary embolism.
intensive care unit admission ratio
intensive care unit admission ratio
Covid-19 Patients without Pulmonary embolism
Clinically demonstared cases infected with COVID-19 who did not develop pulmonary embolism.
intensive care unit admission ratio
intensive care unit admission ratio
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
intensive care unit admission ratio
intensive care unit admission ratio
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uşak University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cevdet Duran, M.D.
Role: PRINCIPAL_INVESTIGATOR
Uşak University Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uşak University
Uşak, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UU-PE001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.